| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
|
Sharman, Jeff
|
|
|
125 |
15 |
p. 2336-2343
|
artikel
|
| 2 |
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
|
Mussai, Francis
|
|
|
125 |
15 |
p. 2386-2396
|
artikel
|
| 3 |
CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells
|
Amé-Thomas, Patricia
|
|
|
125 |
15 |
p. 2381-2385
|
artikel
|
| 4 |
Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E. A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood. 2003;102(7):2506-2512.
|
|
|
|
125 |
15 |
p. 2451
|
artikel
|
| 5 |
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis
|
Héritier, Sébastien
|
|
|
125 |
15 |
p. 2448-2449
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
125 |
15 |
p. i
|
artikel
|
| 7 |
Evens AM, Kostakoglu L. The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Blood. 2014;124(23):3356-3364.
|
|
|
|
125 |
15 |
p. 2450
|
artikel
|
| 8 |
Haplo graft engineering: sculpting to a T
|
Fuchs, Ephraim J.
|
|
|
125 |
15 |
p. 2315-2316
|
artikel
|
| 9 |
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2
|
Rollin, Jérôme
|
|
|
125 |
15 |
p. 2397-2404
|
artikel
|
| 10 |
KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome
|
Magor, Graham W.
|
|
|
125 |
15 |
p. 2405-2417
|
artikel
|
| 11 |
Lung parenchyma-derived IL-6 promotes IL-17A–dependent acute lung injury after allogeneic stem cell transplantation
|
Varelias, Antiopi
|
|
|
125 |
15 |
p. 2435-2444
|
artikel
|
| 12 |
Macro-Quest
|
Rajkumar, S. Vincent
|
|
|
125 |
15 |
p. 2318-2319
|
artikel
|
| 13 |
Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome
|
Schramm, Elizabeth C.
|
|
|
125 |
15 |
p. 2359-2369
|
artikel
|
| 14 |
Minimal residual disease–directed therapy in acute myeloid leukemia
|
Kayser, Sabine
|
|
|
125 |
15 |
p. 2331-2335
|
artikel
|
| 15 |
Mutations in complement C3 from aHUS patients
|
Andersen, Gregers R.
|
|
|
125 |
15 |
p. 2316-2318
|
artikel
|
| 16 |
Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells
|
Wang, Xiaomei
|
|
|
125 |
15 |
p. 2418-2427
|
artikel
|
| 17 |
p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency
|
Belle, Jad I.
|
|
|
125 |
15 |
p. 2344-2348
|
artikel
|
| 18 |
Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays
|
Ding, Qiulan
|
|
|
125 |
15 |
p. 2428-2434
|
artikel
|
| 19 |
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment
|
Sultanik, Philippe
|
|
|
125 |
15 |
p. 2446-2447
|
artikel
|
| 20 |
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes
|
Airoldi, Irma
|
|
|
125 |
15 |
p. 2349-2358
|
artikel
|
| 21 |
The biology and treatment of plasmablastic lymphoma
|
Castillo, Jorge J.
|
|
|
125 |
15 |
p. 2323-2330
|
artikel
|
| 22 |
The cellular origin and malignant transformation of Waldenström macroglobulinemia
|
Paiva, Bruno
|
|
|
125 |
15 |
p. 2370-2380
|
artikel
|
| 23 |
The primacy of IL-6 in IPS?
|
Teshima, Takanori
|
|
|
125 |
15 |
p. 2320-2322
|
artikel
|
| 24 |
Unusual breast mass: lymphoma with crystal-storing histiocytosis
|
Loghavi, Sanam
|
|
|
125 |
15 |
p. 2445
|
artikel
|
| 25 |
Why “R” HIT patients predisposed to thrombosis?
|
Padmanabhan, Anand
|
|
|
125 |
15 |
p. 2319-2320
|
artikel
|
Tijdschrift beschrijving